Resource

 

 

 

 

 

 

 

 

 

 

 

PARTNER MOVES - Freeths bolsters leading national insolvency practice with partner hire

05 Mar 2024

National law firm Freeths has appointed Partner Su Garner to establish a Restructuring and Insolvency team in Leicester.

With more than 20 years’ experience, Su advises clients on a wide range of non-contentious restructuring and insolvency matters. Working across all sectors including construction, retail, hospitality and automotive, she has a particular focus on distressed real estate as well as formal insolvency appointments and security issues.

PARTNER MOVES - Stephenson Harwood strengthens leading marine practice in Middle East

05 Mar 2024

Law firm Stephenson Harwood LLP has strengthened its top-tier marine and international trade practice in the Middle East, with the arrival of two partners, Mohamed El Hawawy and Khurram Ali, and a team of five fee earners.

Stephenson Harwood stands apart from other law firms in the maritime space because of our unique market position, said Eifion Morris, Stephenson Harwood CEO. We have an enviable and rich maritime heritage, and while most other firms have experience weighted towards one area or the other, we have premier ship finance and maritime practices in one firm.

PARTNER MOVES - Freshfields makes major move in private equity with two strategic hires in New York

05 Mar 2024

Freshfields announced that leading private equity M&A attorneys, Neal J. Reenan and Ian N. Bushner*, are joining the firm as partners in New York. Reenan will be Global Co-Head of Private Capital alongside Charles Hayes and Arend von Riegen, and Bushner will serve as Head of U.S. Private Capital.

PARTNER MOVES - Morgan Lewis adds pharma pricing in-house counsel as a partner in Washington, D.C.

04 Mar 2024

Bolstering its capabilities for companies in the life sciences industry, Morgan Lewis welcomes Stephen Forster, who most recently served as senior director and lead counsel of pricing and commercial access strategy at Otsuka Pharmaceutical. As a partner resident in Washington, DC, Steve will advise life sciences companies on drug pricing and commercial contracting matters.